Literature DB >> 27200395

Temporal and Spatial Expression of TGF-b1 in the Early Phase of Patellar Tendon Healing after Application of Platelet Rich Plasma.

Dimitris N Lyras1, Konstantinos Kazakos1, Konstantinos Tilkeridis1, Anna Kokka1, Athanasios Ververidis1, Sotirios Botaitis1, George Agrogiannis1.   

Abstract

BACKGROUND: The aim of this study is to find out the spatial and temporal expression of TGF-b1 during the tendon healing, after application of Platelet Rich Plasma (PRP).
METHODS: A patellar tendon defect model in rabbits was used for this purpose. 48 skeletally mature New Zealand White rabbits, weighing 3.5 kg, were used for this study. Equal numbers of animals from both groups were sacrificed at 4 different time points (1st, 2nd, 3rd, and 4th week). A full thickness patellar tendon substance in the right limb of each animal was excised from its central portion during the operation. PRP with a gel form was applied and filled the tendon defect in PRP group. No PRP was applied in the tendon defect of controls. Histological sections with hematoxylin-eosin and immunohistochemical sections with an anti-TGF-b1 primary antibody were made for the evaluation of the results.
RESULTS: A differentiation of the healing process was observed in the PRP group in comparison with the control group. TGF-b1 expression was detected in various cell populations (inflammatory cells, endothelial cells, macrophages, and tenocytes). Both cytoplasmic and nuclear expressions were present. The larger amounts of immunoexpression were localized in epitenon and in the repair site. PRP group showed stronger and more extensive staining at 1st and 2nd week (P<0.0001), whereas control group showed more extensive staining at the 3(rd) and 4(th) week (P<0.0001).
CONCLUSIONS: Our study demonstrates that locally application of PRP result in an alteration of TGF-b1 expression during the healing of a patellar tendon defect.

Entities:  

Keywords:  Patellar tendon defect; Platelet-Rich Plasma; Rabbits; TGF-b1; Tendon healing

Year:  2016        PMID: 27200395      PMCID: PMC4852043     

Source DB:  PubMed          Journal:  Arch Bone Jt Surg        ISSN: 2345-461X


  19 in total

1.  Platelet-rich plasma (PRP): what is PRP and what is not PRP?

Authors:  R E Marx
Journal:  Implant Dent       Date:  2001       Impact factor: 2.454

2.  Experimental study of tendon healing early phase: is IGF-1 expression influenced by platelet rich plasma gel?

Authors:  D N Lyras; K Kazakos; G Agrogiannis; D Verettas; A Kokka; G Kiziridis; E Chronopoulos; M Tryfonidis
Journal:  Orthop Traumatol Surg Res       Date:  2010-05-07       Impact factor: 2.256

3.  Flexor tendon healing in vitro: effects of TGF-beta on tendon cell collagen production.

Authors:  Matthew B Klein; Naveen Yalamanchi; Hung Pham; Michael T Longaker; James Chang
Journal:  J Hand Surg Am       Date:  2002-07       Impact factor: 2.230

4.  Collagen-platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament.

Authors:  Martha M Murray; Kurt P Spindler; Eduardo Abreu; John A Muller; Arthur Nedder; Mark Kelly; John Frino; David Zurakowski; Maria Valenza; Brian D Snyder; Susan A Connolly
Journal:  J Orthop Res       Date:  2007-01       Impact factor: 3.494

5.  Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion.

Authors:  J Chang; R Thunder; D Most; M T Longaker; W C Lineaweaver
Journal:  Plast Reconstr Surg       Date:  2000-01       Impact factor: 4.730

6.  Expression and secretion of type beta transforming growth factor by activated human macrophages.

Authors:  R K Assoian; B E Fleurdelys; H C Stevenson; P J Miller; D K Madtes; E W Raines; R Ross; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  The effect of platelet-rich plasma gel in the early phase of patellar tendon healing.

Authors:  Dimitris N Lyras; Konstantinos Kazakos; Dionysios Verettas; Sotirios Botaitis; George Agrogiannis; Anna Kokka; Michail Pitiakoudis; Athanasios Kotzakaris
Journal:  Arch Orthop Trauma Surg       Date:  2009-07-21       Impact factor: 3.067

8.  Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences.

Authors:  L M Wakefield; D M Smith; K C Flanders; M B Sporn
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

9.  Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect.

Authors:  Dimitris Lyras; Kostas Kazakos; Dionysios Verettas; Alexandros Polychronidis; Constantinos Simopoulos; Sotirios Botaitis; George Agrogiannis; Anna Kokka; Efstratios Patsouris
Journal:  Int Orthop       Date:  2009-02-11       Impact factor: 3.075

10.  Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.

Authors:  Kyriakos Zafirellis; George Agrogiannis; Aglaia Zachaki; Katerina Gravani; Andreas Karameris; Christos Kombouras
Journal:  J Surg Res       Date:  2007-07-26       Impact factor: 2.192

View more
  4 in total

1.  Healing of Complete Tear of the Anterior Talofibular Ligament and Early Ankle Stabilization after Autologous Platelet Rich Plasma: a Case Report and Literature Review.

Authors:  Mark Wai Wah Lai; Regina Wing Shan Sit
Journal:  Arch Bone Jt Surg       Date:  2018-03

Review 2.  Tendon injuries: Basic science and new repair proposals.

Authors:  Fan Wu; Michael Nerlich; Denitsa Docheva
Journal:  EFORT Open Rev       Date:  2017-07-27

3.  Platelet-rich plasma promotes recruitment of macrophages in the process of tendon healing.

Authors:  Hirofumi Nishio; Yoshitomo Saita; Yohei Kobayashi; Tomoiku Takaku; Shin Fukusato; Sayuri Uchino; Takanori Wakayama; Hiroshi Ikeda; Kazuo Kaneko
Journal:  Regen Ther       Date:  2020-05-15       Impact factor: 3.419

4.  Diminishing effects of mechanical loading over time during rat Achilles tendon healing.

Authors:  Hanifeh Khayyeri; Malin Hammerman; Mikael J Turunen; Parmis Blomgran; Thomas Notermans; Manuel Guizar-Sicairos; Pernilla Eliasson; Per Aspenberg; Hanna Isaksson
Journal:  PLoS One       Date:  2020-12-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.